BioQuest Corp Financials
| BQST Stock | USD 1.12 0.02 1.82% |
BioQuest |
Understanding current and past BioQuest Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioQuest Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in BioQuest Corp's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in BioQuest Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioQuest Corp. Check BioQuest Corp's Beneish M Score to see the likelihood of BioQuest Corp's management manipulating its earnings.
BioQuest Corp Stock Summary
BioQuest Corp competes with Genomma Lab. BioQuest Corp. intends to acquire companies in green energy sector in the United States. BioQuest Corp. was incorporated in 2011 and is based in Newport Beach, California. BIOQUEST CORP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 7 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 4570 Campus Drive, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.bioquestcorp.com |
| Phone | 714 978 4425 |
| Currency | USD - US Dollar |
BioQuest Corp Key Financial Ratios
BioQuest Corp's financial ratios allow both analysts and investors to convert raw data from BioQuest Corp's financial statements into concise, actionable information that can be used to evaluate the performance of BioQuest Corp over time and compare it to other companies across industries.| Return On Asset | -17.31 | |||
| Beta | -38.18 | |||
| Z Score | 3.3 |
BioQuest Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioQuest Corp's current stock value. Our valuation model uses many indicators to compare BioQuest Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioQuest Corp competition to find correlations between indicators driving BioQuest Corp's intrinsic value. More Info.BioQuest Corp is rated below average in return on asset category among its peers. It is rated fifth in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioQuest Corp's earnings, one of the primary drivers of an investment's value.BioQuest Corp Systematic Risk
BioQuest Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioQuest Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on BioQuest Corp correlated with the market. If Beta is less than 0 BioQuest Corp generally moves in the opposite direction as compared to the market. If BioQuest Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioQuest Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioQuest Corp is generally in the same direction as the market. If Beta > 1 BioQuest Corp moves generally in the same direction as, but more than the movement of the benchmark.
BioQuest Corp November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BioQuest Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioQuest Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioQuest Corp based on widely used predictive technical indicators. In general, we focus on analyzing BioQuest Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioQuest Corp's daily price indicators and compare them against related drivers.
| Downside Deviation | 19.54 | |||
| Information Ratio | 0.1031 | |||
| Maximum Drawdown | 84.04 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 16.0 |
Additional Tools for BioQuest Pink Sheet Analysis
When running BioQuest Corp's price analysis, check to measure BioQuest Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioQuest Corp is operating at the current time. Most of BioQuest Corp's value examination focuses on studying past and present price action to predict the probability of BioQuest Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioQuest Corp's price. Additionally, you may evaluate how the addition of BioQuest Corp to your portfolios can decrease your overall portfolio volatility.